AZD3988 |
Inhibitor of DGAT1
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| DGAT1 |
|
|
Inhibitor
up to 100 nM
Selectivity
In Vitro Selectivity Assessment
Potency: IC50 - ACAT1 86 nM, ACAT2 600 nM
Potency Assay Off-Target:
Enzymatic Activity
Selectivity Assessment Description:
no significant activity against DGAT-2, the hERG encoded potassium channel (>30 μM), and cytoc ...
Potency Cellular
In Vitro
DGAT1
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1016/j.bmcl.2012.04.117
In Vivo Validations
Mouse, Rat, Dog
Dose: 0.5 (M), 2 (R), 1 (D) mg/kg IV, 1 (M), 5 (R), 1 (D) mg/kg PO, Reviewer suggest: 20 mg/Kg (M), 0.5-5 mg/Kg (R)
Route of delivery:
Intravenous, Oral
Plasma half life:
4.9 (M), 3.4 (R), 1.8 (D) h (IV), 4.7 (M), 5.8 (R), 5.7 (D) h (PO)
Systemic clearance:
4.6 (M), 1.1 (R), 2.5 (D) mL/min/kg
DOI Reference: 10.1016/j.bmcl.2012.04.117
Orthogonal Probes def
GSK2973980A
Chemical Information
| Molecular Formula | C23H22F2N4O4 |
| SMILEs | O=C(O)C[C@H]1CC[C@H](c2ccc(NC(=O)c3nnc(Nc4ccc(F)c(F)c4)o3)cc2)CC1 |
| InChI | InChI=1S/C23H22F2N4O4/c24-18-10-9-17(12-19(18)25)27-23-29-28-22(33-23)21(32)26-16-7-5-15(6-8-16)14-3-1-13(2-4-14)11-20(30)31/h5-10,12-14H,1-4,11H2,(H,26,32)(H,27,29)(H,30,31)/t13-,14- |
| Molecular weight | 456.16 Da |
| AlogP | 0.0 |
| HBond acceptors | 8 |
| HBond donors | 3 |
| Atoms | 55 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.